Logo image of STSS

SHARPS TECHNOLOGY INC (STSS) Stock Fundamental Analysis

USA - NASDAQ:STSS - US82003F3091 - Common Stock

8.9 USD
-0.22 (-2.41%)
Last: 9/15/2025, 9:58:58 AM
Fundamental Rating

2

Overall STSS gets a fundamental rating of 2 out of 10. We evaluated STSS against 191 industry peers in the Health Care Equipment & Supplies industry. STSS has a great financial health rating, but its profitability evaluates not so good. STSS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

STSS had negative earnings in the past year.
In the past year STSS has reported a negative cash flow from operations.
STSS had negative earnings in each of the past 5 years.
In the past 5 years STSS always reported negative operating cash flow.
STSS Yearly Net Income VS EBIT VS OCF VS FCFSTSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

With a Return On Assets value of -54.41%, STSS is not doing good in the industry: 67.54% of the companies in the same industry are doing better.
STSS has a Return On Equity (-63.94%) which is in line with its industry peers.
Industry RankSector Rank
ROA -54.41%
ROE -63.94%
ROIC N/A
ROA(3y)-83.26%
ROA(5y)-86.74%
ROE(3y)-212.63%
ROE(5y)-179.23%
ROIC(3y)N/A
ROIC(5y)N/A
STSS Yearly ROA, ROE, ROICSTSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for STSS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STSS Yearly Profit, Operating, Gross MarginsSTSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, STSS has more shares outstanding
Compared to 5 years ago, STSS has more shares outstanding
STSS has a worse debt/assets ratio than last year.
STSS Yearly Shares OutstandingSTSS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2K 4K 6K
STSS Yearly Total Debt VS Total AssetsSTSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 51.88 indicates that STSS is not in any danger for bankruptcy at the moment.
The Altman-Z score of STSS (51.88) is better than 100.00% of its industry peers.
There is no outstanding debt for STSS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 51.88
ROIC/WACCN/A
WACCN/A
STSS Yearly LT Debt VS Equity VS FCFSTSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

STSS has a Current Ratio of 4.35. This indicates that STSS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.35, STSS is in the better half of the industry, outperforming 71.73% of the companies in the same industry.
STSS has a Quick Ratio of 3.67. This indicates that STSS is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of STSS (3.67) is better than 71.20% of its industry peers.
Industry RankSector Rank
Current Ratio 4.35
Quick Ratio 3.67
STSS Yearly Current Assets VS Current LiabilitesSTSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.59% over the past year.
EPS 1Y (TTM)55.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.55%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-633.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-95.06%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
STSS Yearly Revenue VS EstimatesSTSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 10B 20B 30B
STSS Yearly EPS VS EstimatesSTSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 -1K -2K -3K -4K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for STSS. In the last year negative earnings were reported.
Also next year STSS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STSS Price Earnings VS Forward Price EarningsSTSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STSS Per share dataSTSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -500 -1K -1.5K -2K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

STSS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SHARPS TECHNOLOGY INC

NASDAQ:STSS (9/15/2025, 9:58:58 AM)

8.9

-0.22 (-2.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-14 2024-05-14/amc
Earnings (Next)N/A N/A
Inst Owners6.11%
Inst Owner Change-42.68%
Ins Owners0.12%
Ins Owner Change48.28%
Market Cap228.55M
Analysts82.86
Price Target22.44 (152.13%)
Short Float %6.14%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-93.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 15.72
P/tB 15.75
EV/EBITDA N/A
EPS(TTM)-2218.66
EYN/A
EPS(NY)-1.12
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0
BVpS0.57
TBVpS0.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -54.41%
ROE -63.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-83.26%
ROA(5y)-86.74%
ROE(3y)-212.63%
ROE(5y)-179.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 316.61%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.35
Quick Ratio 3.67
Altman-Z 51.88
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)192.36%
Cap/Depr(5y)2248.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.55%
EPS Next Y-633.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-95.06%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.84%
OCF growth 3YN/A
OCF growth 5YN/A